Supplementary Table S3 from Intracranial Efficacy of Selpercatinib in <i>RET</i> Fusion-Positive Non–Small Cell Lung Cancers on the LIBRETTO-001 Trial

crossref（2023）

引用 0|浏览55

暂无评分

摘要

Tumor response of patients with RET fusion-positive NSCLC & non-measurable intracranial disease

查看译文

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要

Supplementary Table S3 from Intracranial Efficacy of Selpercatinib in &lt;i&gt;RET&lt;/i&gt; Fusion-Positive Non–Small Cell Lung Cancers on the LIBRETTO-001 Trial